A client has prescriptions for albuterol (Proventil HFA) and salmeterol (Serevent). Which instruction should the nurse provide for this client?

A) Cardiogenic shock:
Cardiogenic shock occurs when the heart is unable to pump enough blood to meet the body's needs, often due to myocardial infarction (heart attack) or other conditions affecting the heart's function. The client's history of a recent infection does not align with the etiology of cardiogenic shock.

B) Neurogenic shock:
Neurogenic shock occurs due to dysfunction of the autonomic nervous system, typically as a result of spinal cord injury or severe brain injury. It is characterized by widespread vasodilation and bradycardia. The client's history of a recent infection does not align with the etiology of neurogenic shock.

C) Hypovolemic shock:
Hypovolemic shock occurs due to a significant loss of blood volume, such as from trauma, hemorrhage, or dehydration. While infection can lead to fluid loss and dehydration in some cases, the client's history of a recent infection suggests a different etiology, specifically septic shock, which is driven by the systemic inflammatory response to infection.

D) Septic shock.
Septic shock is a type of distributive shock caused by a systemic response to infection. It occurs when an infection triggers a widespread inflammatory response, leading to vasodilation, increased capillary permeability, fluid loss from the bloodstream, and impaired tissue perfusion. The client's history of a recent infection suggests that the shock may be septic in nature.

A. The medication will relieve wheezing: Albuterol is a short-acting beta agonist bronchodilator that works by quickly relaxing the smooth muscles of the airways, leading to rapid bronchodilation. This helps relieve symptoms such as wheezing, shortness of breath, and chest tightness commonly associated with asthma exacerbations.

B. The medication will reduce inflammation: Albuterol is not primarily indicated for reducing inflammation in asthma. While it can help alleviate symptoms of bronchospasm, it does not target the underlying inflammation associated with asthma.

C. The medication will increase the amount of mucus: Albuterol does not increase mucus production. In fact, it is a bronchodilator medication that primarily targets airway smooth muscle relaxation and bronchodilation to improve airflow and relieve symptoms.

D. The medication will decrease coughing episodes: Albuterol can help decrease coughing episodes by relieving bronchospasm and improving airflow. However, its primary mechanism of action is bronchodilation rather than directly targeting coughing.

E. The medication will open the airways: Albuterol works by stimulating beta-2 adrenergic receptors in the airway smooth muscles, resulting in relaxation of these muscles and dilation of the bronchial tubes. This action helps to open the airways, allowing for improved airflow and easier breathing.